Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1364092.RA18todSDn7KA37jp7ctg78HtjB65RR6tVzBLJwOhbkbg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1364092.RA18todSDn7KA37jp7ctg78HtjB65RR6tVzBLJwOhbkbg130_assertion type Assertion NP1364092.RA18todSDn7KA37jp7ctg78HtjB65RR6tVzBLJwOhbkbg130_head.
- NP1364092.RA18todSDn7KA37jp7ctg78HtjB65RR6tVzBLJwOhbkbg130_assertion description "[Considering only those patients with cerebral toxoplasmosis from whom CSF was collected before or during the first week of antitoxoplasmic therapy, sensitivity rose to 50%.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1364092.RA18todSDn7KA37jp7ctg78HtjB65RR6tVzBLJwOhbkbg130_provenance.
- NP1364092.RA18todSDn7KA37jp7ctg78HtjB65RR6tVzBLJwOhbkbg130_assertion evidence source_evidence_literature NP1364092.RA18todSDn7KA37jp7ctg78HtjB65RR6tVzBLJwOhbkbg130_provenance.
- NP1364092.RA18todSDn7KA37jp7ctg78HtjB65RR6tVzBLJwOhbkbg130_assertion SIO_000772 8958252 NP1364092.RA18todSDn7KA37jp7ctg78HtjB65RR6tVzBLJwOhbkbg130_provenance.
- NP1364092.RA18todSDn7KA37jp7ctg78HtjB65RR6tVzBLJwOhbkbg130_assertion wasDerivedFrom befree-2016 NP1364092.RA18todSDn7KA37jp7ctg78HtjB65RR6tVzBLJwOhbkbg130_provenance.
- NP1364092.RA18todSDn7KA37jp7ctg78HtjB65RR6tVzBLJwOhbkbg130_assertion wasGeneratedBy ECO_0000203 NP1364092.RA18todSDn7KA37jp7ctg78HtjB65RR6tVzBLJwOhbkbg130_provenance.